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RAPID COMMUNICATION
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Methylprednisolone normalizes superoxide anion production by poly-
morphs from patients with ANCA-positive vasculitides. It has been
convincingly documented that reactive oxygen species released from
activated neutrophils mediate glomerular damage in experimental gb-
merulonephritis. Recent findings that antineutrophil cytoplasmic au-
toantibodies (ANCA) induce neutrophils to degranulate and produce
oxygen radicals in vitro led us to explore whether neutrophils from
patients with ANCA-positive vasculitides and necrotizing glomerulone-
phritis generated an increased amount of superoxide anion (02). Since
glucocorticoids inhibit oxygen radicals generation in vitro we also
evaluated the effect of intravenous pulses of methyiprednisolone.
Polymorphs were isolated from peripheral blood collected before (bas-
al), 6 and 24 hours after the first infusion of methylprednisobone and 24
hours after the third one. 02 release by cells was assessed after 30
minute incubation without specific stimuli. Basal 02 release was
significantly higher in patients than in controls (P < 0.01). Intravenous
infusion of high doses of methylprednisolone markedly reduced 02
production with respect to the basal value, and the difference was
statistically significant at various time interval considered after the
steroid infusion. Besides reducing the excessive 02 formation, meth-
ylprednisolone induced an increase in polymorph expression of the
gene encoding for manganese superoxide dismutase (Mn-SOD) en-
zyme. We conclude that polymorphs taken from patients with ANCA-
positive vasculitides and necrotizing glomerulonephritis generate higher
amounts of 02 than those from normal subjects. Methylprednisolone
normalizes the abnormal generation of 02, likely through its ability to
up-regulate the gene for Mn-SOD, a potent antioxidant enzyme.
Necrotizing glomerular damage and renal failure are charac-
teristic features of those forms of renal vasculitides that are
associated with circulating antineutrophil cytoplasmic autoanti-
bodies (ANCA) [11. More than simply a serologic marker of this
group of diseases, ANCA have been suspected to play a
pathogenetic role by inducing normal human neutrophils to
degranulate and release oxygen radicals including superoxide
anion (02) [2—4]. Such a property is shared by the two most
common categories of antineutrophil antibodies: the one with
mainly a cytoplasmic pattern (c-ANCA) as well as the myelo-
peroxidase (MPO)-specific one [3], The relevance of this mech-
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anism to human disease rests on two important lines of evi-
dence. One is that oxygen radicals released from activated
leukocytes are directly toxic to cultured endothelial cells [5—7],
and the second is that anti-MPO antibody-stimulated neutro-
phils cause injury to human endothelial cells in culture [81. That
reactive oxygen species may induce renal injury has also been
documented in vivo as long as antioxidant enzymes and/or
oxygen radical scavengers protect animals with antiglomerular
basement membrane glomerulonephritis from proteinuria and
glomerular damage [9, 101. At the renal level, reactive oxygen
species, because of their vasoactive properties, also cause
hemodynamic changes [11]. Thus rats given intravenous phor-
bol myristate acetate had a fall in single nephron glomerular
filtration rate and an increase in renal arteriolar resistance that
were prevented by catalase, an antioxidant enzyme [11]. Both
in experimental animals and in humans glucocorticoids limit
glomerular injury, as documented in the past by a multitude of
studies [12, 13]. Of interest, data are available that glucocorti-
coids inhibit oxygen radical production by polymorphs in vitro
[14—18]. Therefore the possibility exists that glucocorticoids
independently of their immunosuppressive properties also re-
duce oxygen radical dependent damage. However, in vivo the
effect of glucocorticoids on oxygen radicals is less clear.
Nelson, Wennhold and Murray have reported that dexametha-
sone given orally to healthy subjects significantly reduced 02
production by unstimulated or concanavalin A-treated leuko-
cytes [19], but this has not been confirmed by a more recent
study [201. In disease conditions, Marcolongo et al have found
that different glucocorticoids such as deflazacort, methyipred-
nisolone and betamethasone given orally to patients with rheu-
matoid arthritis effectively suppress ex vivo' 02 production
by polymorphs [15]. The aims of the present study were: (1) to
explore whether polymorphs taken from patients with ANCA-
positive vasculitides and necrotizing glomerulonephritis gener-
ated abnormal amounts of 02, and (2) to verify whether high
dose steroids given to these patients as part of their treatment
protocol [21, 22] inhibited the excessive 02 generation.
Methods
Subjects
Six consecutive patients (5 males and 1 female with a mean
age of 44 years, range 23 to 60) who had been referred to the
215
216 Macconi et a!: Steroids and ANCA -positive renal vasculitides
Table 1. Clinical and laboratory findings of patients
Patients
Serum
creatinine
mg/dl
Proteinuria
g/24 hr
ANCA
IIF
pattern
ELISAb
a-granules
U
MPO
I 3.6 0.3 p <6 562
2 10.8 1.5 c 110 <10
3 3.2 12.0 c 51 26
4 1.5 4.3 c 64 40
5 3.4 2.3 p <6 >1000
6 10,9 0.2 c 49 23
a p, perinuclear; c, cytoplasmicb ANCA-ELISA, normal values: a-granules  15 U; MPO  90 U
Division of Nephrology and Dialysis of the Ospedali Riuniti di
Bergamo between May 1991 and October 1992 were enrolled in
the study. Informed consent was obtained from each patient.
Enrollment criteria were the presence of a biopsy proven
glomerulopathy that would have required, by commonly used
protocols, treatment with glucocorticoids alone or in combina-
tion with immunosuppressive agents. Exclusion criteria were
previous exposure to glucocorticoids or cytotoxic drugs, con-
comitant hematological diseases, neoplasia, moderate hyper-
tension, need for blood transfusion and uremia requiring dialy-
sis. Renal biopsy specimens were examined by light,
immunofluorescence and electron microscopy by a single renal
pathologist. All patients had an extracàpillary necrotizing gb-
merulonephritis and were seropositive for ANCA. Autoanti-
body positivity was defined by either a cytoplasmic (c) or
perinuclear (p) pattern of neutrophil staining shown by indirect
immunofluorescence microscopy (hF), and by a positive
screening enzyme-linked immunosorbent assay (ELISA) using
as c-ANCA antigen the neutrophil a-granule fraction and as
p-ANCA antigen the purified MPO. Clinical and laboratory
findings are reported in Table 1. Six healthy volunteers (5 males
and 1 female with a mean age of 41 years, range 23 to 62) were
studied simultaneously.
Study design
Patients were treated according to the protocols of Bolton
and Couser and O'Neill et al [21, 22], which include 15 mg/kg
methyiprednisolone by a 25-minute intravenous infusion for
three consecutive days followed by oral therapy for one year (1
mg/kg prednisone and subsequent tapering combined with 2
mg/kg cyclophosphamide). These patients were studied in basal
conditions and at different time intervals during the three days
of treatment with intravenous methylprednisolone. Specifically
to assess the effect of intravenous pulses of methylprednisolone
on 'ex vivo' 02 production by polymorphs, peripheral blood
was drawn before the first infusion of the steroid and at the
following time intervals thereafter: 6 and 24 hours after the first
infusion and 24 hours after the third infusion of methyipred-
nisolone. Polymorphs taken from healthy volunteers were used
as controls.
Detection of ANCA by hF
Staining patterns were determined as being perinuclear or
diffuse cytoplasmic by hF using alcohol-fixed cytocentrifuge
preparations obtained from normal human neutrophils as sub-
strate [23]. Briefly, 50 jsl of patients' sera diluted 1:16 in
phosphate-buffered saline (PBS) were overlaid on the cytoprep-
arations and incubated for 40 minutes at room temperature.
After three washes with PBS (10 mm each), 50 j.d of F(ab')2 goat
anti-human total Ig-FITC (Kallestad, Austin, Texas, USA)
diluted 1:80 in PBS were added and incubated for 40 minutes at
room temperature. Slides were then washed as before, mounted
in buffered-glycerol and examined by fluorescence microscopy
SM-Lux (Leitz-Wetzlar, Germany). Each assay included a
known positive serum for each pattern and a negative control
serum. Assays were performed without knowledge of clinical or
renal biopsy data.
Detection of ANCA by ELISA
ELISA for c-ANCA antibodies was performed using as
antigen the Triton X- 100 extract of neutrophil a-granule fraction
obtained by nitrogen cavitation of normal human neutrophils
followed by density gradient separation with Percoll (Pharmacia
Fine Chemicals, Uppsala, Sweden) according to Rasmussen et
al [24]. Microtiter plates (Greiner, Frickenhausen, Germany)
were coated with 100 d of a-granule preparation in 25 mM
phosphate buffer pH 11.9 overnight at 4°C. After one hour
incubation at 37°C with blocking buffer (PBS supplemented
with 1% BSA) and subsequent washings in PBS, 0.05% Tween
20, patients' sera diluted 1:50 in incubation buffer (PBS supple-
mented with 1% BSA, 0.1% Tween 20) were added in duplicate,
as well as serial dilutions of a strongly ANCA-positive serum as
a standard. Plates were incubated for one hour at 37°C and then
washed three times with PBS, 0.05% Tween 20. Affinity purified
goat anti-human IgG-phosphatase labeled (KPL, Gaithersburg,
Missouri, USA) was diluted 1:1500 in incubation buffer, added
to the plates and incubated as described above. After three
washes with PBS, 0.05% Tween 20, the substrate disodium
p-nitrophenyl phosphate (Sigma Chemical Co., St. Louis, Mis-
souri, USA) was added. After one hour, optical densities were
measured at 405 nm using a Titertek Multiskan MR spectropho-
tometer (ICN-Flow, Irvine, California, USA) interfaced with an
Apple lie computer (Apple Computer Inc., Cupertino, Califor-
nia, USA). Optical density values of patients' sera were ex-
pressed as arbitrary units calculated by means of a calibration
curve, which was constructed from the absorbance values
obtained for the standard. A positive ELISA was defined by a
value greater than the mean value for a normal population (90
healthy donors) plus two standard deviations. ELISA for MPO
antibodies was performed using as antigen the commercially
available (Calbiochem, La Jolla, California, USA) MPO at a
concentration of 1.6 tg/ml. All the procedures were identical to
those used for ELISA for c-ANCA except that the coating was
done in carbonate buffer pH 9.6 and patients' sera were diluted
1:100.
Isolation of polymorphs
Heparinized (10 U/mI) venous blood was diluted with an
equal volume of 0.9% NaCI and layered on Ficoll-Paque (Phar-
macia) [25]. After centrifugation at 400 x g for 40 minutes at 18
to 20°C, the bottom fraction containing the erythrocytes and
granubocytes was mixed with 4 volumes of Emagel (Behring-
werke AG, Marburg, Germany) and erythrocytes were allowed
to sediment at 4°C for about 30 minutes. Thereafter supernatant
was removed, centrifuged at 500 x g for seven minutes at 4°C
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and the pellet washed once by centrifugation in Ca2 and Mg2
free-Hanks balanced salt solution (HBSS) (Tris 27.5 mM,
Na2HPO4 0.7 mi'vi, KH2PO4 0.74 mi.i, KC1 5.4 mM, NaC1 136
mM, dextrose 9.6 mM). The contaminating erythrocytes were
removed by ammonium chloride lysis at 4°C and subsequent
centrifugation. The cell suspension contained about 95% poly-
morphs which were greater than 98% viable as determined by
trypan blue dye exclusion.
Measurement of 02 production
Superoxide generation was measured by SOD-inhibitable
reduction of ferricytochrome c [26]. Polymorphs (1 X 106) were
incubated in duplicate samples in 1 ml of HBSS supplemented
with CaCl2 1.87 m and MgSO4 0.8 m in the presence of 80
/.M ferricytochrome c (horse heart, grade III, Sigma Chemical
Co.) with or without 30 tg/ml of SOD (approximately 3000
U/mg protein, Sigma). After 30 minutes of incubation at 37°C in
a shaking bath cells were removed by centrifugation (500 x g
for 7 mm) and the amount of reduced cytochrome c was
determined from the absorbance at 550 nm by using the
extinction coefficient of 21.1 cm' . Data were expressed
as nmoles of 02_/106 cells/30 minutes.
Particular care was taken in standardizing the interval be-
tween sample collection and neutrophil isolation, and between
neutrophil isolation and superoxide anion measurement. For
this assay control samples were run in parallel with patient
samples under identical in vitro incubation conditions,
Human Mn-SOD cDNA cloning
Two oligonucleotides were prepared using a 380 B automatic
DNA synthesizer (Applied Biosystems). The sense primer
(oligo 1: 5 'GACATCGTCGACATGGATTATTTTCCCGT-
GATC) and the antisense primer (oligo 2: S'GTCAGCGTC-
GACCTGTAGTCAATGTGCTCGGTT) were synthesized cor-
responding to the sequence of nucleotides 110-131 and to the
complementary sequence of nucleotides 641-661 of human
Mn-SOD cDNA [27], respectively, and having Sal I linker at
their 5' ends. One microgram of human mononuclear cell total
RNA was reverse-transcribed to cDNA by AMW reverse
transcriptase (Boehringer) using oligo 2 as a primer. The cDNA
encoding human Mn-SOD was amplified by polymerase chain
reaction using a DNA Thermal Cycler 4600 (Perkin Elmer
Cetus, Norwalk, Connecticut, USA). PCR was performed at a
final concentration of 1 x PCR buffer/SO tM dNTP/0. 1 sM each
sense and antisense oligos/2.S U of Taq DNA Polymerase
(Perkin Elmer Cetus) in a total volume of 100 pA. The amplifi-
cation profile involved denaturation at 94°C for one minute,
primer annealing at 72°C for one minute and extension at 72°C
for 2.5 minutes. The cycle was repeated 30 times. The product
of PCR amplification was Sal I digested, gel purified and
inserted into pTZl9 vector (Pharmacia). By sequencing using
the dideoxynucleotide chain termination method [28] the am-
plification product was verified to be identical to the region
included between nucleotide 110 to 661 of human Mn-SOD
cDNA published by Ho and Crapo [27].
RNA isolation from polymorphs and Northern blot analysis
Total RNA was isolated from polymorphs by guanidium
isothiocyanate/cesium chloride procedure [29]. For Northern
blot analysis, 3 g of total RNA from polymorphs of patients
before and after treatment with methylprednisolone were frac-
tionated on 1.2% formaldehyde agarose gel and blotted onto
synthetic membranes (Gene Screen Plus, New England Nu-
clear, Boston, Massachusetts, USA). Human Mn-SOD eDNA
was labeled by a random-primed labeling method using (a-32P)
dCTP [30]. Membranes were hybridized at 60°C with 1 x 106
cpm/ml labeled probe in a solution containing 1 M NaCI, 1%
sodium dodecyl sulfate (SDS), 10% dextran sulfate and 100
g/ml of salmon sperm DNA. After 20 hours hybridization
filters were washed at 60°C in 1 x standard saline citrate
(SSC)/l% SDS for one hour. Following rehybridization of the
same membranes with a rat cDNA fragment for the housekeep-
ing gene glyceraldehyde phosphate dehydrogenase (GAPDH)
[31] the relative signal intensities were quantitated by a laser
scanning densitometer (Desaga GmpH, Heidelberg, Germany).
Statistical analysis
Results are expressed as geometric means (antilog 95%
confidence interval of the logarithms) owing to their skewed
distribution. Statistical analysis was performed after a normal-
izing transformation (natural logarithms) of the original values
to minimize correlation between mean and the variance. 02
production by polymorphs from patients and normal subjects
was compared using Student's t-test. Results on the effect of
methylprednisolone were analyzed by a Repeated Measures
Analysis of Variance carried out using GLM procedure of the
SAS/STAT statistical package [32], running a HP 9000/400.
Statistical significance was defined as P < 0.05.
Results
02 generation by polymorphs 'ex vivo'
As shown in Figure 1, the basal O2 production by polymor-
phs was significantly (P < 0.01) higher in patients with ANCA-
positive vasculitides and necrotizing glomerulonephritis than in
sex and age matched healthy subjects (6.50 (4.61 to 9.17) versus
2.89 (1.74 to 4.77) nmol O2_/l06 cells/30 minutes).
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Fig. 1. Basal 'ex vivo' 02 production by polymorphs (PMN5) from
patients with ANCA -positive vasculitides and necrotizing glomerulone-
phritis and controls. Points represent single experimental values; lines
are geometric means. * P < 0.01 versus controls.
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Six hours after the first intravenous infusion of 15 mg/kg
methyiprednisolone, 02 production by polymorphs was sig-
nificantly reduced to about 50% of the basal values (P <0.01)
and further decreased 24 hours thereafter (P < 0.001; Fig. 2).
The inhibitory effect was sustained, so that the amount of 02
produced by the cells even 24 hours after the third steroid
infusion was significantly lower as compared to pretreatment
values (P < 0.01), and actually comparable to normal [2.17 (0.94
to 5.0) vs. 2.89 (1.74 to 4.77) nmol 02_/106 cells/30 mm; Fig. 2].
To determine whether methylprednisolone induced in our
patient polymorphs' Mn-SOD gene, blots of total RNA from
these cells were probed with radiolabeled Mn-SOD cDNA.
Figure 3 (upper panel) shows a representative Northern analy-
sis of mRNA for Mn-SOD from polymorphs of a patient before
and after methylprednisolone (15 mg/kg) infusion. Following
the steroid infusion, transcripts of identical size but of greater
intensity were observed in polymorphs. The intensity of the
signals from the major transcript for Mn-SOD was used for the
quantitation of mRNA induction. Rehybridization of the mem-
brane with GAPDH eDNA [311 showed that induction of
Mn-SOD by methylprednisolone was specific. The levels of
Mn-SOD gene expression were 63% and 78% higher 6 and 24
hours after the first infusion of methylprednisolone, respec-
tively, and 69% higher 24 hours after the third infusion of the
steroid (lower panel).
Discussion
In the present study we have documented that polymorphs
taken 'ex vivo' from patients with ANCA-positive vasculitides
and necrotizing glomerulonephritis produced significant higher
amounts of 02 than polymorphs from healthy subjects. The
increased O2 production by these cells is consistent with in
vitro data that ANCA stimulate the release of reactive oxygen
species from normal human neutrophils [31. The mechanisms by
which O2 may promote glomerular injury has not been estab-
lished yet. One possibility is that 02 reacts with hydrogen
peroxide in presence of ferrous iron to form the highly toxic and
Ohr 6hr 24hr 24°hr
Fig. 3. A. Representative Northern blot analysis of Mn-SOD gene.
Total RNA (3 gig) isolated from polymorphs of a patient before (0 hr),
6 and 24 hours after the first infusion and 0 24 hours after the third
infusion of 15 mg/kg methyiprednisolone (MP) was fractionated in 1.2%
formaldehyde agarose gel, transferred on nylon membrane and hybrid-
ized with radiolabeled human Mn-SOD cDNA. B. Densitometric anal-
ysis of the corresponding autoradiograph. The optical density of the
autoradiographic signals was quantitated and calculated as the ratio of
Mn-SOD to the housekeeping GAPDH mRNA. The basal mRNA level
(0 hr) was assigned the number 1 and the values which followed the
steroid infusion were calculated relative to that number.
reactive hydroxyl radical [33]. In this circumstance the acidic
pH at the site of inflammation could facilitate O2 action in
releasing ferrous iron from transferrin [34]. Several lines of
evidence have indicated hydroxyl radical as one of the main
determinant of neutrophil-mediated endothelial injury [7] as
well as of proteinuria in experimental models of renal disease
[10]. A recent study has documented that O2 can also react
with nitric oxide to form peroxynitrite anion which rapidly
decomposes to give a strong oxidant with reactivity similar to
the hydroxyl radical [35]. An alternative possibility is that O2
may potentiate oxidant damage by boosting MPO-dependent
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Fig. 2. 'Ex vivo' O2 production by polymorphs (PMN5) from patients
before (0 hr), 6 and 24 hours after the first infusion and 024 hours after
the third infusion of 15 mg/kg methyiprednisolone (MP). Bold horizon-
tal lines represent geometric means. * P < 0.01, ** P < 0.001 versus
basal values (0 hr).
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production of hypochiorous acid [361 which in its turn can
activate the neutrophil metalloproteinases [37, 381 that alter
glomerular permeability [39]. Finally 02 by generating chemo-
tactic factors [40], participates in polymorph recruiting process
that amplifies the inflammatory injury. This latter mechanism
has been proposed as an explanation for the 02 dependent
accumulation of polymorphs at sites of dermal and pulmonary
vasculitis [41] and can also occur at glomerular level. Whether
the increased oxygen radical production in neutrophils from
patients with vasculitis are simply a parameter of disease
activity is also a possibility to take into account.
The second finding of the present study is that intravenous
pulses of methylprednisolone markedly reduced the excessive
generation of 02 by polymorphs. The mechanism(s) of the
protective effect of glucocorticoids in this system is still ill
defined. A previous study which also documented an effect of
dexamethasone to suppress 02 production by leukocytes [19]
has found a parallel change in the phospholipid composition of
these cells. This has been taken to suggest that by changing the
phospholipid composition of the membrane glucocorticoids
interfere with the 02 forming enzyme NADPH-oxidase. This
interpretation is substantiated by the finding that hydrocorti-
sone significantly reduced the max for NADPH of the oxidase
and inhibited the reconstitution of NADPH-oxidase by sodium
dodecyl sulfate in a cell-free system indicating a direct effect of
reducing the enzyme activity [18]. More recently several stud-
ies have emphasized that glucocorticoids may increase the
activity of antioxidant enzymes. In vitro evidence is available
that methylprednisolone raises catalase and Mn-SOD activity in
bovine glomerular endothelial cells in culture exposed to of-
fending stimuli and this results in a reduced production of
hydrogen peroxide [42]. In vivo methyiprednisolone given to
normal rats for both three days and nine days significantly
enhances glomerular antioxidant enzyme activities [43]. Such
an effect has also been documented in rats with puromycin
aminonucleoside induced nephrosis and may explain the prop-
erty of the steroid in reducing oxidant-mediated proteinuria and
renal injury in this model [43]. The possibility that glucocorti-
coids increase antioxidant enzyme activities through an up-
regulation of the genes encoding for the corresponding enzymes
has been suggested by a recent study showing that methylpred-
nisolone potently induced Mn-SOD mRNA in bovine glomeru-
lar endothelial cells [44]. Our present finding offers the first
evidence in vivo in humans that methylprednisolone treatment
of patients with ANCA-positive vasculitides and necrotizing
glomerulonephritis up-regulates Mn-SOD gene expression in
polymorphs. Since up-regulation of Mn-SOD gene parallels to
the reduced generation of O2 in polymorphs, we speculate that
the effect of methylprednisolone in limiting O2 production in
these patients could be related to a positive regulation of
Mn-SOD gene.
In conclusion, we have documented that polymorphs taken
from patients with ANCA-positive vasculitides and necrotizing
glomerulonephritis generate excessive amounts of O2. Meth-
ylprednisolone, besides reducing 02, increases Mn-SOD
mRNA in polymorphs. It is possible that the effect of the steroid
of limiting the inflammatory response in this disease is linked to
a positive regulation of Mn-SOD gene that likely limits the
consequences of excessive local generation of 02. The alter-
native possibility however that glucocorticoid effects on neu-
trophils' oxygen radical production and Mn-SOD gene are
nonspecific and unrelated to the therapeutic effect of the drug
can not be ruled out.
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